{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:24:11Z","timestamp":1787228651243,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tranon.2026.102923","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:44:51Z","timestamp":1784223891000},"page":"102923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TMC7 promotes colorectal cancer metastasis via inhibition of PKN2 and regulation of hypoxia-adaptive responses"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-8643","authenticated-orcid":false,"given":"Yun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2881-6565","authenticated-orcid":false,"given":"Yongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102923_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases - a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12957-021-02140-6","article-title":"Nomogram based on homogeneous and heterogeneous associated factors for predicting distant metastases in patients with colorectal cancer","volume":"19","author":"Luo","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.tranon.2026.102923_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112870","article-title":"14-3-3\u03c3-NEDD4L axis promotes ubiquitination and degradation of HIF-1\u03b1 in colorectal cancer","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.tranon.2026.102923_bib0006","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.tranon.2026.102923_bib0007","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11033-015-3858-x","article-title":"Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K","volume":"42","author":"Courtnay","year":"2015","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0008","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12964-025-02514-3","article-title":"USP13 promotes colorectal cancer progression by deubiquitinating and stabilizing HIF-1\u03b1","volume":"23","author":"Gu","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"5930","key":"10.1016\/j.tranon.2026.102923_bib0009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tranon.2026.102923_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ebiom.2019.01.003","article-title":"Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma","volume":"40","author":"Cheng","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-017-0747-z","article-title":"PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1\/2 pathway","volume":"17","author":"Cheng","year":"2018","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.tranon.2026.102923_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.70050","article-title":"PKN2 Inhibits VEGFA and bFGF-Mediated Angiogenesis by Targeting HIF-1\u03b1 in colon cancer","volume":"41","author":"Zhu","year":"2025","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"5","key":"10.1016\/j.tranon.2026.102923_bib0013","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.18632\/oncotarget.6633","article-title":"Protein kinase D2 contributes to TNF-\u03b1-induced epithelial mesenchymal transition and invasion via the PI3K\/GSK-3\u03b2\/\u03b2-catenin pathway in hepatocellular carcinoma","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.tranon.2026.102923_bib0014","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.dld.2017.12.015","article-title":"Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGF\u03b21\/Smad3 pathway","volume":"50","author":"Cheng","year":"2018","journal-title":"Dig. Liver Dis."},{"issue":"6282","key":"10.1016\/j.tranon.2026.102923_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.tranon.2026.102923_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.tranon.2026.102923_bib0017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2014.12.018","article-title":"Extracellular metabolic energetics can promote cancer progression","volume":"160","author":"Loo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.102923_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40880-016-0083-5","article-title":"Mechanisms of vascularization in murine models of primary and metastatic tumor growth","volume":"35","author":"Bugyik","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.102923_bib0019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ijc.26016","article-title":"Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility","volume":"130","author":"Castro","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.102923_bib0020","first-page":"809","article-title":"Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck","volume":"27","author":"Antonsson","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.tranon.2026.102923_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biochi.2019.07.017","article-title":"Transmembrane Channel-Like 5 (TMC5) promotes prostate cancer cell proliferation through cell cycle regulation","volume":"165","author":"Zhang","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.tranon.2026.102923_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715508","article-title":"Pan-cancer analysis reveals the signature of TMC family of genes as a promising biomarker for prognosis and immunotherapeutic response","volume":"12","author":"Song","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0023","article-title":"Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma","volume":"13","author":"Tang","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.tranon.2026.102923_bib0024","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102923_bib0025","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.102923_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.tranon.2026.102923_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.149","article-title":"Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2274","article-title":"The interplay between MYC and HIF in cancer","volume":"8","author":"Dang","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.102923_bib0029","article-title":"Redox regulation of cancer stem cells: biology and therapeutic implications","volume":"3","author":"Du","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.tranon.2026.102923_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100755","article-title":"The PKC universe keeps expanding: from cancer initiation to metastasis","volume":"78","author":"Rahimova","year":"2020","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.tranon.2026.102923_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2026.101446","article-title":"Protein kinase D: integrating cancer and metabolic disorders","volume":"108","author":"Shemy","year":"2026","journal-title":"Mol. Asp. Med."},{"issue":"4","key":"10.1016\/j.tranon.2026.102923_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110227","article-title":"Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion","volume":"38","author":"Murray","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0033","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10020-025-01132-6","article-title":"PKN2 enhances the immunosuppressive activity of polymorphonuclear myeloid-derived suppressor cells in esophageal carcinoma by mediating fatty acid oxidation","volume":"31","author":"Fu","year":"2025","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102923_bib0034","first-page":"547","article-title":"Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"45","key":"10.1016\/j.tranon.2026.102923_bib0035","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1021\/bi401216w","article-title":"Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB","volume":"52","author":"Hutchinson","year":"2013","journal-title":"Biochemistry"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:27:11Z","timestamp":1787225231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S1936523326002597"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102923","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TMC7 promotes colorectal cancer metastasis via inhibition of PKN2 and regulation of hypoxia-adaptive responses","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102923"}}